Chronic Lung Disease of Prematurity Completed Phase 3 Trials for Budesonide (DB01222)

Also known as: Bronchopulmonary Dysplasia / Dysplasia, Bronchopulmonary / Ventilator lung in newborn / Congenital pulmonary fibrosis

IndicationStatusPhase
DBCOND0044076 (Chronic Lung Disease of Prematurity)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01035190Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary DysplasiaPrevention